Cost Utility Analysis of Dapagliflozin in Egyptian Patients with CKD from the Payer Perspective

ISSN Print: 2164-2842
ISSN Online: 2164-2869
www.scirp.net/journal/ojneph
E-mail: [email protected]

Citations

"Cost Utility Analysis of Dapagliflozin in Egyptian Patients with CKD from the Payer Perspective"
written by Gamal Saadi, Magdy Elsharkawy, Gamal Fathy El-Naggar, Ahmed F. Elkeraie, Emad R. Issak,
published by Open Journal of Nephrology, Vol.13 No.4, 2023

has been cited by the following article(s):

No relevant information.

[1]	A cost-utility analysis of adding SGLT2 inhibitors for the management of type 2 diabetes with chronic kidney disease in Thailand Scientific Reports, 2025 DOI:10.1038/s41598-024-81747-7